We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
751
DELISTED
Everi Holdings
EVRI
| $1.6M | 0.02% |
193,423
+125,061
| +183% | +$868K |
|
752
PUT
Oracle
ORCL
$331B
| $1.59M | 0.02% |
+26,700
| New | +$1.52M |
|
753
Constellation Brands
STZ
$22.2B
| $1.59M | 0.02% |
8,395
-127,897
| -94% | -$23.3M |
|
754
LGI Homes
LGIH
$1.4B
| $1.59M | 0.02% |
13,690
-1,588
| -10% | -$176K |
|
|
755
CALL
Oracle
ORCL
$331B
| $1.59M | 0.02% |
+26,600
| New | +$1.51M |
|
756
Pacira BioSciences
PCRX
$1.02B
| $1.58M | 0.02% |
26,321
+16,906
| +180% | +$982K |
|
757
Radian Group
RDN
$5.14B
| $1.58M | 0.02% |
108,244
+56,189
| +108% | +$837K |
|
758
Credicorp
BAP
$30.9B
| $1.58M | 0.02% |
12,737
+9,723
| +323% | +$1.25M |
|
759
Kinross Gold
KGC
$28.5B
| $1.58M | 0.02% |
179,012
+158,823
| +787% | +$1.37M |
|
760
United Rentals
URI
$71.1B
| $1.58M | 0.02% |
9,047
+1,552
| +21% | +$261K |
|
761
CALL
Amazon
AMZN
$2.5T
| $1.57M | 0.02% |
10,000
-4,000
| -29% | -$631K |
|
|
762
PUT
Amazon
AMZN
$2.5T
| $1.57M | 0.02% |
10,000
-4,000
| -29% | -$631K |
|
763
CALL
Citigroup
C
$222B
| $1.56M | 0.02% |
+36,300
| New | +$1.81M |
|
|
764
PUT
Citigroup
C
$222B
| $1.56M | 0.02% |
+36,300
| New | +$1.81M |
|
765
Northwest Bancshares
NWBI
$2.25B
| $1.56M | 0.02% |
169,739
-121,287
| -42% | -$1.2M |
|
|
AVTA
766
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.56M | 0.02% |
165,612
+138,569
| +512% | +$1.53M |
|
767
Diageo
DEO
$46.2B
| $1.56M | 0.02% |
+11,308
| New | +$1.56M |
|
768
Upland Software
UPLD
$12M
| $1.56M | 0.02% |
4,128
+3,474
| +531% | +$1.25M |
|
769
Avery Dennison
AVY
$12.3B
| $1.55M | 0.02% |
12,159
-50,952
| -81% | -$6.01M |
|
770
Nutanix
NTNX
$14.9B
| $1.54M | 0.02% |
+69,660
| New | +$1.59M |
|
771
Applied Materials
AMAT
$426B
| $1.54M | 0.02% |
25,967
-90,113
| -78% | -$5.57M |
|
|
DVAX
772
DELISTED
Dynavax Technologies
DVAX
| $1.54M | 0.02% |
357,134
+302,115
| +549% | +$2.16M |
|
773
Prestige Consumer Healthcare
PBH
$2.35B
| $1.54M | 0.02% |
42,345
-50,390
| -54% | -$1.87M |
|
774
LCI Industries
LCII
$2.51B
| $1.54M | 0.02% |
14,491
-1,095
| -7% | -$127K |
|
|
VSPRU
775
DELISTED
Vesper Healthcare Acquisition Corp. Unit
VSPRU
| $1.54M | 0.02% |
+150,000
| New | +$1.54M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.